Recently published research from GlobalData, "GlycoZym - Product Pipeline Analysis, 2014 Update", is now available at Fast Market Research
Boston, MA -- (SBWIRE) -- 09/30/2014 -- Glycozym is a biotechnology company. The company develops HTP platform for production of PTM-peptide microarrays for the analysis of protein interactions affected by posttranslational modifications. Its products include PTM-pepscan, PTM-pepome, PTM-peplibrary, and O-PTM-biomarkers. Glycozym provides services related to the PTM-peptide platform which includes ready-to-use PTM-peptide arrays, and custom build PTM-peptide libraries and arrays, as well as custom designed analysis. The company uses proprietary algorithms to design, synthesize, construct, and screen PTM-peptides and proteins, such as extended O-glycopeptides with defined plycan structures. It offers products and services to academic and industrial communities on customized basis. GlycoZym is headquartered in Beverly, Massachusetts, the US.
View Full Report Details and Table of Contents
This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
The report analyzes all pipeline products in development for the company GlycoZym
The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
The report provides detailed description of products in development, technical specification and functions
The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
To formulate effective Research & Development strategies
Develop market-entry and market expansion strategies
Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc
Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
About Fast Market Research
Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.
Browse all Medical Devices research reports at Fast Market Research
You may also be interested in these related reports:
- Qiagen N.V. (QIA) - Product Pipeline Analysis, 2014 Update
- Boston Scientific Corporation (BSX) - Product Pipeline Analysis, 2014 Update
- St. Jude Medical, Inc. (STJ) - Product Pipeline Analysis, 2014 Update
- Quidel Corporation (QDEL) - Product Pipeline Analysis, 2014 Update
- Alere Inc. (ALR) - Product Pipeline Analysis, 2014 Update
- Medtronic, Inc. (MDT) - Product Pipeline Analysis, 2014 Update
- Roche Diagnostics Limited - Product Pipeline Analysis, 2014 Update
- Cepheid (CPHD) - Product Pipeline Analysis, 2014 Update
- Becton, Dickinson and Company (BDX) - Product Pipeline Analysis, 2014 Update
- Siemens Healthcare - Product Pipeline Analysis, 2014 Update